KLOW vs Wolverine: Comparing the Indexed Record
KLOW and Wolverine appear together in search far more often than they appear together in published methodology. That gap is the useful part.
Compound profiles
KLOW in the indexed record
Indexed output for KLOW stands at 199 records, a moderate literature, alongside 1 registered studies on ClinicalTrials.gov.
Publications carrying this compound include Lancet, Tidsskr Nor Laegeforen, spanning 2004–2019.
- (+/-)-2-(N-Phenethyl-N-1′-[(11)C]propyl)amino-5-hydroxytetralin — , 2004. PMID: 20641291
- (R)-2-[(11)C]Methoxy-N-n-propylnorapomorphine — , 2004. PMID: 20641879
- (R)-(-)-2-Chloro-N-[1-(11)C-propyl]n-propylnorapomorphine — , 2004. PMID: 21204317
- Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial — Lancet, 2012. PMID: 22172244
Wolverine in the indexed record
Indexed output for Wolverine stands at 162 records, a moderate literature, alongside 22 registered studies on ClinicalTrials.gov.
Journals represented in the current index include Cogn Behav Pract, Ecol Evol, iScience, spanning 2021–2025.
- A framework for collaborative wolverine connectivity conservation — iScience, 2021. PMID: 34368656
- An Estimate of Wolverine Density for the Canadian Province of Alberta — Ecol Evol, 2025. PMID: 39744459
- Implementation of the Wolverine Mental Health Program, Part 1: Adoption Phase — Cogn Behav Pract, 2022. PMID: 35280926
How the literature differs
The indexed record is not symmetrical between these two compounds. KLOW carries 37 more indexed records than Wolverine, which means published methodology, characterisation data and replication attempts are more readily located for KLOW. For a researcher planning a literature review, that asymmetry usually determines which compound has established reference protocols and which requires primary-source work.
Registered study counts (1 vs 22) track a different signal — formal study registration rather than published output — and the two figures frequently diverge.
Side-by-side research profile
| Parameter | KLOW | Wolverine |
|---|---|---|
| PubMed indexed records | 199 | 162 |
| Registered studies (ClinicalTrials.gov) | 1 | 22 |
| Literature depth | Moderate | Moderate |
| Handling class | Lyophilised powder | Lyophilised powder |
| Designation | Research use only | Research use only |
Classification and why it matters
KLOW and Wolverine sit in different structural classes, and that classification is what determines whether a published protocol for one has any bearing on the other. Peptide research compounds are grouped by sequence length, origin and the receptor families the literature associates with them — not by the outcome a reader might be looking for.
Reading across classes is the most common error in a literature review. A protocol developed for KLOW describes conditions validated for KLOW: concentration ranges, solvent choice, incubation windows and control selection were all established against that compound. Applying those same conditions to Wolverine without re-validation produces data that cannot be compared back to the source publication.
Where the two compounds are studied in overlapping models, the published work almost always treats them as separate arms rather than as substitutes. That separation is the useful signal: it indicates the research record does not consider them equivalent.
Verification and documentation
What is in the vial is established by lot-specific analytics, not by label text. HPLC gives purity as a share of total peak area; mass spectrometry confirms the molecular weight matches the intended sequence. Neither substitutes for the other.
Laboratory handling
Both compounds ship as lyophilised powder. Convention is storage of the sealed vial at -20°C away from light, with reconstitution immediately before experimental use. In solution, peptides are materially less stable than in lyophilised form.
Freeze-thaw cycling degrades integrity; aliquoting after reconstitution avoids repeatedly cycling one vial.
Frequently asked questions
How should these compounds be stored?
Lyophilised material is conventionally stored at -20°C protected from light. Reconstituted solution is far less stable and is held at 2-8°C for short-duration laboratory work only.
Which of KLOW or Wolverine has more published research?
KLOW, with 199 indexed PubMed records against 162.
Are KLOW and Wolverine the same compound?
No. They are structurally distinct research compounds with separate literature records — 199 indexed records for KLOW and 162 for Wolverine.
What is the regulatory status of these compounds?
Neither is an approved drug. Both are supplied strictly for in-vitro laboratory research and are not intended for human or veterinary consumption.
Related references
- KLOW — product and lot documentation
- Certificate of analysis & purity testing
- Research reference index
Research use only. The compounds discussed are supplied for in-vitro laboratory research. They are not drugs, are not approved for the diagnosis, treatment, cure or prevention of any condition, and are not intended for human or veterinary consumption.